cytokine inhibitor (Teijin)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Namecytokine inhibitor (Teijin)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCytokines modulators

TargetsCytokines

Therapy Area/IndicationsArteriosclerosisArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTeijin Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTeijin Pharma

Active IndicationsN/A

Inactive IndicationsArteriosclerosisArthritis, Rheumatoid

ATC CodeN/A